Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Geier

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
North American Journal of Medical Sciences|December 10, 2014
Thimerosal-containing hepatitis B vaccination and the risk for diagnosed specific delays in development in the United States: a case-control study in the vaccine safety datalinkDavid A Geier, Janet K Kern, Brian S Hooker, et al.
International Journal of Environmental Research and Public Health|September 9, 2014
A dose-response relationship between organic mercury exposure from thimerosal-containing vaccines and neurodevelopmental disordersDavid A Geier, Brian S Hooker, Janet K Kern, et al.
International Journal of Environmental Research and Public Health|August 23, 2013
Thimerosal exposure and the role of sulfation chemistry and thiol availability in autismJanet K Kern, Boyd E Haley, David A Geier, et al.
Translational Neurodegeneration|December 21, 2013
A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United StatesDavid A Geier, Brian S Hooker, Janet K Kern, et al.
Acta Neurobiologiae Experimentalis|January 18, 2017
Immune dysfunction and neuroinflammation in autism spectrum disorderGeir Bjorklund, Khaled Saad, Salvatore Chirumbolo, et al.
Brain Connectivity|January 21, 2015
Shared Brain Connectivity Issues, Symptoms, and Comorbidities in Autism Spectrum Disorder, Attention Deficit/Hyperactivity Disorder, and Tourette SyndromeJanet K Kern, David A Geier, Paul G King, et al.
Journal of the Neurological Sciences|September 27, 2008
Biomarkers of environmental toxicity and susceptibility in autismDavid A Geier, Janet K Kern, Carolyn R Garver, et al.
Acta Neurobiologiae Experimentalis|January 26, 2018
Developmental neurotoxicants and the vulnerable male brain: a systematic review of suspected neurotoxicants that disproportionally affect malesJanet K Kern, David A Geier, Kristin G Homme, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|June 2, 2011
A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disordersDavid A Geier, Janet K Kern, Georgia Davis, et al.
Journal of Strength and Conditioning Research|July 25, 2013
Handgrip strength in autism spectrum disorder compared with controlsJanet K Kern, David A Geier, James B Adams, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
North American Journal of Medical Sciences|December 10, 2014
Thimerosal-containing hepatitis B vaccination and the risk for diagnosed specific delays in development in the United States: a case-control study in the vaccine safety datalinkDavid A Geier, Janet K Kern, Brian S Hooker, et al.
International Journal of Environmental Research and Public Health|September 9, 2014
A dose-response relationship between organic mercury exposure from thimerosal-containing vaccines and neurodevelopmental disordersDavid A Geier, Brian S Hooker, Janet K Kern, et al.
International Journal of Environmental Research and Public Health|August 23, 2013
Thimerosal exposure and the role of sulfation chemistry and thiol availability in autismJanet K Kern, Boyd E Haley, David A Geier, et al.
Translational Neurodegeneration|December 21, 2013
A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United StatesDavid A Geier, Brian S Hooker, Janet K Kern, et al.
Acta Neurobiologiae Experimentalis|January 18, 2017
Immune dysfunction and neuroinflammation in autism spectrum disorderGeir Bjorklund, Khaled Saad, Salvatore Chirumbolo, et al.
Brain Connectivity|January 21, 2015
Shared Brain Connectivity Issues, Symptoms, and Comorbidities in Autism Spectrum Disorder, Attention Deficit/Hyperactivity Disorder, and Tourette SyndromeJanet K Kern, David A Geier, Paul G King, et al.
Journal of the Neurological Sciences|September 27, 2008
Biomarkers of environmental toxicity and susceptibility in autismDavid A Geier, Janet K Kern, Carolyn R Garver, et al.
Acta Neurobiologiae Experimentalis|January 26, 2018
Developmental neurotoxicants and the vulnerable male brain: a systematic review of suspected neurotoxicants that disproportionally affect malesJanet K Kern, David A Geier, Kristin G Homme, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|June 2, 2011
A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disordersDavid A Geier, Janet K Kern, Georgia Davis, et al.
Journal of Strength and Conditioning Research|July 25, 2013
Handgrip strength in autism spectrum disorder compared with controlsJanet K Kern, David A Geier, James B Adams, et al.
Pageof 13